U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Partial Thromboplastin Time, CTCAE

MedGen UID:
409542
•Concept ID:
C1963058
•
Finding

Recent clinical studies

Etiology

Nonresectable hepatocellular carcinoma: long-term toxicity in patients treated with transarterial chemoembolization--single-center experience.
Buijs M, Vossen JA, Frangakis C, Hong K, Georgiades CS, Chen Y, Liapi E, Geschwind JF
Radiology 2008 Oct;249(1):346-54. doi: 10.1148/radiol.2483071902. PMID: 18796686Free PMC Article

Therapy

Phase I clinical study of the toll-like receptor 9 agonist MGN1703 in patients with metastatic solid tumours.
Weihrauch MR, Richly H, von Bergwelt-Baildon MS, Becker HJ, Schmidt M, Hacker UT, Shimabukuro-Vornhagen A, Holtick U, Nokay B, Schroff M, Wittig B, Scheulen ME
Eur J Cancer 2015 Jan;51(2):146-56. Epub 2014 Dec 2 doi: 10.1016/j.ejca.2014.11.002. PMID: 25480557
Nonresectable hepatocellular carcinoma: long-term toxicity in patients treated with transarterial chemoembolization--single-center experience.
Buijs M, Vossen JA, Frangakis C, Hong K, Georgiades CS, Chen Y, Liapi E, Geschwind JF
Radiology 2008 Oct;249(1):346-54. doi: 10.1148/radiol.2483071902. PMID: 18796686Free PMC Article

Prognosis

Nonresectable hepatocellular carcinoma: long-term toxicity in patients treated with transarterial chemoembolization--single-center experience.
Buijs M, Vossen JA, Frangakis C, Hong K, Georgiades CS, Chen Y, Liapi E, Geschwind JF
Radiology 2008 Oct;249(1):346-54. doi: 10.1148/radiol.2483071902. PMID: 18796686Free PMC Article

Supplemental Content

Table of contents

    Recent activity

    Clear Turn Off Turn On

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...